These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2491287)

  • 21. Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice.
    Lichtenstein AK; Berek J; Kahle J; Zighelboim J
    Cancer Res; 1984 Nov; 44(11):5118-23. PubMed ID: 6488171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effect between neutrophils and Corynebacterium parvum in the process of macrophage activation.
    Chapes SK; Haskill S
    Cancer Res; 1984 Jan; 44(1):31-4. PubMed ID: 6228293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
    Weinhold KJ; Bolognesi DP; Matthews TJ
    J Natl Cancer Inst; 1985 Oct; 75(4):717-24. PubMed ID: 3862904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of Corynebacterium parvum in influenza infected mice.
    Białek J; Denys A; Kowalska M; Ciebiada I; Szydłowska T
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):421-30. PubMed ID: 2639639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.
    Howell LE; Kreider JW; Bartlett GL
    J Natl Cancer Inst; 1986 Jul; 77(1):187-93. PubMed ID: 3487670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 27. [The use of Corynebacterium parvum in pleurodesis].
    Helin T; Haahtela T
    Duodecim; 1988; 104(4):262-5. PubMed ID: 3168834
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
    Tomecki J; Sukiennik J; Kordowiak A
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells.
    Tomecki J; Mara M
    Neoplasma; 1987; 34(1):15-22. PubMed ID: 3031518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accessory cell function in tumor-bearing mice and effects of Corynebacterium parvum.
    Okuda S; Taniguchi K; Kubo C; Nomoto K
    J Natl Cancer Inst; 1982 Dec; 69(6):1293-7. PubMed ID: 6292563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of Corynebacterium parvum.
    Milas L; Scott MT
    Adv Cancer Res; 1978; 26():257-306. PubMed ID: 343523
    [No Abstract]   [Full Text] [Related]  

  • 32. Induced regression of bovine papillomas by intralesional immunotherapy.
    Hall H; Teuscher C; Urie P; Boden B; Robison R
    Ther Immunol; 1994 Dec; 1(6):319-24. PubMed ID: 7584507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline.
    Leahy BC; Honeybourne D; Brear SG; Carroll KB; Thatcher N; Stretton TB
    Eur J Respir Dis; 1985 Jan; 66(1):50-4. PubMed ID: 3979476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulators in the treatment of peritonitis in burned and malnourished animals.
    Waymack JP; Miskell P; Gonce SJ; Alexander JW
    Surgery; 1984 Aug; 96(2):308-14. PubMed ID: 6379960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.
    Thatcher N; Honeybourne D; Wagstaff J; Carroll KB; Barber PV; Morrison JB; Crowther D
    Br J Dis Chest; 1984 Jan; 78(1):89-97. PubMed ID: 6318791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of intravenous Corynebacterium parvum on gut associated mononuclear phagocytes in normal and tumour bearing rats.
    Souter RG; Steer HW
    Clin Exp Immunol; 1982 Dec; 50(3):487-94. PubMed ID: 7165995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of different fractions of Corynebacterium parvum on the cytotoxic T-cell response to alloantigens in mice.
    Lichtenstein A; Tuttle R; Cantrell J; Zighelboim J
    J Natl Cancer Inst; 1982 Aug; 69(2):495-501. PubMed ID: 6213807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway.
    Albina JE; Mills CD; Henry WL; Caldwell MD
    J Immunol; 1989 Dec; 143(11):3641-6. PubMed ID: 2584712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful immunotherapy with intraperitoneal Corynebacterium parvum in a murine ovarian cancer model is associated with the recruitment of tumor-lytic neutrophils into the peritoneal cavity.
    Lichtenstein AK; Kahle J; Berek J; Zighelboim J
    J Immunol; 1984 Jul; 133(1):519-26. PubMed ID: 6373934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.